Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Conditions

Stage I Ovarian Epithelial Cancer | Stage I Primary Peritoneal Cavity Cancer | Stage IA Fallopian Tube Cancer | Stage IB Fallopian Tube Cancer | Stage IC Fallopian Tube Cancer | Stage II Ovarian Epithelial Cancer | Stage II Primary Peritoneal Cavity Cancer | Stage IIA Fallopian Tube Cancer | Stage IIB Fallopian Tube Cancer | Stage IIC Fallopian Tube Cancer | Stage III Ovarian Epithelial Cancer | Stage III Primary Peritoneal Cavity Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Primary Peritoneal Cavity Cancer

What is the purpose of this trial?

This trial studies the chemotherapy toxicity on quality of life in older patients with stage I, stage II, stage III, or stage IV ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer. Learning about the side effects of chemotherapy in older patients may help doctors plan better ways to treat cancer.



Participation Guidelines

Age:
75 Years - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Gynecologic Oncology Group
National Cancer Institute (NCI)
Dates:
August 2011
Last Updated:
March 25, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT01366183